NCT04706338 Transcranial Magnetic Stimulation in the Rehabilitation of Postoperative Motor Dysfunction. Status UNKNOWN Phase NA
NCT04699773 LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138) Status RECRUITING Phase NA
NCT04667715 Safety and Effectiveness of Blood-Brain Barrier Disruption (BBBD) in Subjects With Suspected Infiltrating Glioma Status WITHDRAWN Phase NA
NCT04617002 Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas Status APPROVED_FOR_MARKETING Phase N/A
NCT04550663 NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors Status UNKNOWN Phase PHASE1
NCT04543201 Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade Glioma Status RECRUITING Phase NA
NCT04541225 Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors Status TERMINATED Phase PHASE1
NCT04539574 An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors Status COMPLETED Phase NA
NCT04521686 Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04461002 Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas. Status COMPLETED Phase N/A
NCT04446416 Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients Status COMPLETED Phase NA
NCT04424966 Infigratinib in Recurrent High-Grade Glioma Patients Status TERMINATED Phase EARLY_PHASE1